928 related articles for article (PubMed ID: 17276663)
1. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
[TBL] [Abstract][Full Text] [Related]
2. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
Attama AA; Müller-Goymann CC
Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system.
Kalam MA; Sultana Y; Ali A; Aqil M; Mishra AK; Chuttani K
J Drug Target; 2010 Apr; 18(3):191-204. PubMed ID: 19839712
[TBL] [Abstract][Full Text] [Related]
4. Further characterization of theobroma oil-beeswax admixtures as lipid matrices for improved drug delivery systems.
Attama AA; Schicke BC; Müller-Goymann CC
Eur J Pharm Biopharm; 2006 Nov; 64(3):294-306. PubMed ID: 16949805
[TBL] [Abstract][Full Text] [Related]
5. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
Garg A; Singh S
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909
[TBL] [Abstract][Full Text] [Related]
6. A critical study of novel physically structured lipid matrices composed of a homolipid from Capra hircus and theobroma oil.
Attama AA; Müller-Goymann CC
Int J Pharm; 2006 Sep; 322(1-2):67-78. PubMed ID: 16828247
[TBL] [Abstract][Full Text] [Related]
7. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
[TBL] [Abstract][Full Text] [Related]
8. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
[TBL] [Abstract][Full Text] [Related]
10. Stability of lipid excipients in solid lipid nanoparticles.
Radomska-Soukharev A
Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
[TBL] [Abstract][Full Text] [Related]
11. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN).
Helgason T; Awad TS; Kristbergsson K; McClements DJ; Weiss J
J Colloid Interface Sci; 2009 Jun; 334(1):75-81. PubMed ID: 19380149
[TBL] [Abstract][Full Text] [Related]
12. Chemical stability of lipid excipients in SLN-production of test formulations, characterisation and short-term stability.
Radomska-Soukharev A; Müller RH
Pharmazie; 2006 May; 61(5):425-30. PubMed ID: 16724540
[TBL] [Abstract][Full Text] [Related]
13. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
[TBL] [Abstract][Full Text] [Related]
14. Structural investigations on lipid nanoparticles containing high amounts of lecithin.
Schubert MA; Harms M; Müller-Goymann CC
Eur J Pharm Sci; 2006 Feb; 27(2-3):226-36. PubMed ID: 16298113
[TBL] [Abstract][Full Text] [Related]
15. Physicochemical characterization of sildenafil-loaded solid lipid nanoparticle dispersions (SLN) for pulmonary application.
Paranjpe M; Finke JH; Richter C; Gothsch T; Kwade A; Büttgenbach S; Müller-Goymann CC
Int J Pharm; 2014 Dec; 476(1-2):41-9. PubMed ID: 25261709
[TBL] [Abstract][Full Text] [Related]
16. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Fang JY; Fang CL; Liu CH; Su YH
Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
[TBL] [Abstract][Full Text] [Related]
17. Non-destructive methods of characterization of risperidone solid lipid nanoparticles.
Rahman Z; Zidan AS; Khan MA
Eur J Pharm Biopharm; 2010 Sep; 76(1):127-37. PubMed ID: 20470882
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.
Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929
[TBL] [Abstract][Full Text] [Related]
19. Characterization of ergocalciferol loaded solid lipid nanoparticles.
Patel MR; San Martin-Gonzalez MF
J Food Sci; 2012 Jan; 77(1):N8-13. PubMed ID: 22260120
[TBL] [Abstract][Full Text] [Related]
20. Characterization and stability of nanostructured lipid carriers as drug delivery system.
Abbasalipourkabir R; Salehzadeh A; Abdullah R
Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
